You know the saying about having too much of a good thing? I think that’s me, right now, as I think about starting infusions of the multiple sclerosis drug Lemtrada on Dec. 5.
Lemtrada is supposed to be a super drug. As I wrote in an earlier column, my neurologist calls it “stem cell lite.” Some wheelchair-bound MS patients have been able to take some steps after completing a course of Lemtrada. Others report similar improvements in other symptoms.